Find verified Dacomitinib monhydrate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Dacomitinib monhydrate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Dacomitinib monhydrate API.
Alternate Names: Vizimpro, 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-, (2E)-
CAS No: 1042385-75-0
PubChem CID: 70693519
Mol Formula: C24H27ClFN5O3
Mol Weight: 488.0 g/mol
IUPAC Name: (E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide;hydrate
API Description: Dacomitinib, designed as (2E)-N-16-4-(piperidin-1-yl) but-2-enamide, is an oral highly selective quinazalone part of the second-generation tyrosine kinase inhibitors which are characterized by the irreversible binding at the ATP domain of the epidermal growth factor receptor family kinase domains.
